A global database of plant services for humankind

Humanity faces the challenge of conserving the attributes of biodiversity that may be essential to secure human wellbeing. Among all the organisms that are beneficial to humans, plants stand out as the most important providers of natural resources. Therefore, identifying plant uses is critical to preserve the beneficial potential of biodiversity and to promote basic and applied research on the relationship between plants and humans. However, much of this information is often uncritical, contradictory, of dubious value or simply not readily accessible to the great majority of scientists and policy makers. Here, we compiled a genuslevel dataset of plant-use records for all accepted vascular plant taxa (13489 genera) using the information gathered in the 4th Edition of Mabberley’s plant-book, the most comprehensive global review of plant classification and their uses published to date. From 1974 to 2017 all the information was systematically gathered, evaluated, and synthesized by David Mabberley, who reviewed over 1000 botanical sources including modern Floras, monographs, periodicals, handbooks, and authoritative websites. Plant uses were arranged across 28 standard categories of use following the Economic Botany Data Collection Standard guidelines, which resulted in a binary classification of 9478 plant-use records pertaining human and animal nutrition, materials, fuels, medicine, poisons, social and environmental uses. Of all the taxa included in the dataset, 33% were assigned to at least one category of use, the most common being “ornamental” (26%), “medicine” (16%), “human food” (13%) and “timber” (8%). In addition to a readily available binary matrix for quantitative analyses, we provide a control text matrix that links the former to the description of the uses in Mabberley’s plant-book. We hope this dataset will serve to establish synergies between scientists and policy makers interested in plant-human interactions and to move towards the complete compilation and classification of the nature’s contributions to people upon which the wellbeing of future generations may depen

Tendencias de la Co-creación de valor y el desempeño organizacional

Title: Trends of value co-creation and organizational performance: a bibliometric analysis Innovative companies are characterized by involving different actors to obtain new products and services or improve existing ones and thus affect their performance. The co-creation of value, as an antecedent of organizational performance, plays an important role within organizations, for which the objective of this study is to know the trends of the co-creation of value together with organizational performance. The lack of studies that combine them was evidenced through the bibliometric method. From 81 articles, the more relevant contents were analyzed, journals where they were published, contributing authors on the subject and the related keywords. Gaps in the literature related to intellectual capital, governance, and organizational ambidexterity were identified.Las empresas innovadoras se caracterizan por involucrar diferentes actores para obtener nuevos productos y servicios o mejorar los existentes y así repercutir en su desempeño. La co-creación de valor, como un antecedente del desempeño organizacional, juega un papel importante dentro de las organizaciones, por lo cual el objetivo del presente estudio es conocer las tendencias de la co-creación de valor junto al desempeño organizacional. Se evidenció a través del método bibliométrico la carencia de estudios que las combinen. A partir de 81 artículos, se analizaron las revistas donde fueron publicados, los autores contribuyentes en el tema y las palabras clave relacionadas. Se identificaron vacíos en la literatura relacionados con el capital intelectual, la gobernanza y la ambidestreza organizacional

Comparison of global responses to mild deficiency and excess copper levels in Arabidopsis seedlings

[EN] Copper is an essential micronutrient in higher plants, but it is toxic in excess. The fine adjustments required to fit copper nutritional demands for optimal growth are illustrated by the diverse, severe symptoms resulting from copper deficiency and excess. Here, a differential transcriptomic analysis was done between Arabidopsis thaliana plants suffering from mild copper deficiency and those with a slight copper excess. The effects on the genes encoding cuproproteins or copper homeostasis factors were included in a CuAt database, which was organised to collect additional information and connections to other databases. The categories overrepresented under copper deficiency and copper excess conditions are discussed. Different members of the categories overrepresented under copper deficiency conditions were both dependent and independent of the general copper deficiency transcriptional regulator SPL7. The putative regulatory elements in the promoter of the copper deficiency overrepresented genes, particularly of the iron superoxide dismutase gene FSD1, were also analysed. A 65 base pair promoter fragment, with at least three GTAC sequences, was found to be not only characteristic of them all, but was responsible for most of the FSD1 copper-dependent regulations. Moreover, a new molecular marker for the slight excess copper nutritional status is proposed. Taken together, these data further contribute to characterise copper nutritional responses in higher plants.We thank Dr Toshiharu Shikanai for the spl7 mutant and the Unitat d'Analisi Elemental, Serveis Cientificotecnics at the Universitat de Barcelona. This work has been supported by Grants BIO2011-24848 and CSD2007-00057 to L.P. from the Spanish Ministry of Economy and Competitiveness, and by FEDER funds from the European Union and the Generalitat Valenciana (Regional Valencian Government; ACOMP07-159). N.A.-C., A.G.-M. and A.P.-G were recipients of predoctoral fellowships from the Spanish Ministry of Economy and Competitiveness.Andres-Colas, N.; Perea García, A.; Mayo, S.; Garcia-Molina, A.; Dorcey, E.; Rodríguez-Navarro, S.; Perez Amador, MA.... (2013). Comparison of global responses to mild deficiency and excess copper levels in Arabidopsis seedlings. Metallomics. 5(9):1234-1246. https://doi.org/10.1039/c3mt00025g123412465

Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer

We studied MET alterations in 474 advanced non-small-cell lung cancer (NSCLC) patients by nCounter, an RNA-based technique. We identified 3% with MET Δex14 mRNA and 3.5% with very-high MET mRNA expression, a surrogate of MET amplification. MET alterations identified by nCounter correlated with clinical benefit from MET inhibitors. Quantitative mRNA-based techniques can improve the selection of patients for MET-targeted therapies. MET inhibitors have shown activity in non-small-cell lung cancer patients (NSCLC) with MET amplification and exon 14 skipping (METΔex14). However, patient stratification is imperfect, and thus, response rates have varied widely. Here, we studied MET alterations in 474 advanced NSCLC patients by nCounter, an RNA-based technique, together with next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and reverse transcriptase polymerase chain reaction (RT-PCR), exploring correlation with clinical benefit. Of the 474 samples analyzed, 422 (89%) yielded valid results by nCounter, which identified 13 patients (3%) with MET Δex14 and 15 patients (3.5%) with very-high MET mRNA expression. These two subgroups were mutually exclusive, displayed distinct phenotypes and did not generally coexist with other drivers. For MET Δex14, 3/8 (37.5%) samples positive by nCounter tested negative by NGS. Regarding patients with very-high MET mRNA, 92% had MET amplification by FISH and/or NGS. However, FISH failed to identify three patients (30%) with very-high MET RNA expression, among which one received MET tyrosine kinase inhibitor treatment deriving clinical benefit. Our results indicate that quantitative mRNA-based techniques can improve the selection of patients for MET-targeted therapies

Internal Marketing Orientation: an empirical research in hotel sector

The study has three aims. First, to measure internal market orientation second, to analyze the relation-ships between IMO and two organizational consequences: job satisfaction and commitment; and third,to incorporate a new sub-dimension work/family balance. Empirical research has been done in a sampleof Spanish hotels. Results show that IMO is a strategic determinant of both job satisfaction and employeecommitment

Impact of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients: A nationwide study in Spain

Objective To assess the effect of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients in Spain. Settings The initial flood of COVID-19 patients overwhelmed an unprepared healthcare system. Different measures were taken to deal with this overburden. The effect of these measures on neurosurgical patients, as well as the effect of COVID-19 itself, has not been thoroughly studied. Participants This was a multicentre, nationwide, observational retrospective study of patients who underwent any neurosurgical operation from March to July 2020. Interventions An exploratory factorial analysis was performed to select the most relevant variables of the sample. Primary and secondary outcome measures Univariate and multivariate analyses were performed to identify independent predictors of mortality and postoperative SARS-CoV-2 infection. Results Sixteen hospitals registered 1677 operated patients. The overall mortality was 6.4%, and 2.9% (44 patients) suffered a perioperative SARS-CoV-2 infection. Of those infections, 24 were diagnosed postoperatively. Age (OR 1.05), perioperative SARS-CoV-2 infection (OR 4.7), community COVID-19 incidence (cases/10 5 people/week) (OR 1.006), postoperative neurological worsening (OR 5.9), postoperative need for airway support (OR 5.38), ASA grade =3 (OR 2.5) and preoperative GCS 3-8 (OR 2.82) were independently associated with mortality. For SARS-CoV-2 postoperative infection, screening swab test <72 hours preoperatively (OR 0.76), community COVID-19 incidence (cases/10 5 people/week) (OR 1.011), preoperative cognitive impairment (OR 2.784), postoperative sepsis (OR 3.807) and an absence of postoperative complications (OR 0.188) were independently associated. Conclusions Perioperative SARS-CoV-2 infection in neurosurgical patients was associated with an increase in mortality by almost fivefold. Community COVID-19 incidence (cases/10 5 people/week) was a statistically independent predictor of mortality. Trial registration number CEIM 20/217

CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative

Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Funder: Funder: Fundación bancaria ‘La Caixa’ Number: LCF/PR/PR16/51110003 Funder: Grifols SA Number: LCF/PR/PR16/51110003 Funder: European Union/EFPIA Innovative Medicines Initiative Joint Number: 115975 Funder: JPco-fuND FP-829-029 Number: 733051061Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease

New insights into the genetic etiology of Alzheimer's disease and related dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele